Announcements Call for Application for HEaL Institute’s Short-Duration Intensive Training Program of in Public Health Ethics to be held at Tata Institute of Social Sciences during April 14-17, 2020   |   Call for applications by The Migration Health South Asia Network for skill & capacity development training workshop to be held in 6-9 April 2020   |   Open Letter: Stop the war on Syria’s hospitals

Taking biotechnology to the patient: at what cost?

D Varatharajan


Enlargement of people’s choices is one form of human development. To this extent, biotechnology as a treatment option for certain human ailments such as genetic disorders can be taken as an effort towards human development, as it definitely extends the range of choices available to the public. The issue of ‘taking biotechnology to the patient’ goes beyond mere technology development, which is a supply side activity that may not take into account the demand side requirements such as accessibility and affordability-two important attributes for the success of any intervention technique.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US